NANOG and breast carcinoma: In breast cancer, hypoxia-inducible factor 1α (HIF1α) and HIF-2α stimulate the expression of ALKBH5 which can demethylate NANOG mRNA and increase its stability, inducing the breast cancer stem cell (BCSC) phenotype [111].